Drug makes struggling to set up next year's business plan

Published: 2007-10-31 06:56:00

Updated: 2007-10-31 06:56:00

Tougher anticorruption measures to be slapped by the Fair Trade Commission (FTC), along with the government's relentless slash on drug prices, are casting a shadow over drug makers' business program next year, fueling concerns that domestic pharmaceutical industry could be shattered.

"If we go...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK